Literature DB >> 33743655

Differentiation and management of hepatobiliary mucinous cystic neoplasms: a single centre experience for 8 years.

Jiaqi Gao1, Junhao Zheng1, Jingwei Cai1, Mubarak Ali Kirih1, Junjie Xu1, Liye Tao1, Yuelong Liang1, Xu Feng1, Jing Fang1, Xiao Liang2.   

Abstract

BACKGROUND: Hepatobiliary mucinous cystic neoplasms (H-MCNs) are relatively rare cystic neoplasms in the liver. The differential diagnosis of H-MCNs remains big challenging, and the management and prognosis between the hepatic simple cyst (HSC) and H-MCNs are quite different. This study aimed to present our experience in the management of H-MCNs and provide a preoperative H-MCNs risk prediction nomogram to differentiating H-MCNs from liver cystic lesions.
METHODS: 29 patients diagnosed with H-MCNs and 75 patients diagnosed with HSC between June 2011 and June 2019 at Zhejiang University School of medicine, Sir Run-Run Shaw Hospital were reviewed in this study. We analyzed the demographic and clinicopathological variables.
RESULTS: US, CT, and MRI could accurately diagnose only 3.4%, 46.1%, and 57.1% of H-MCNs, respectively. After univariate analysis and multivariate logistic regression analysis, the variables significantly associated with H-MCNs were enhancement after contrast (p = 0.009), tumour located in the left lobe (p = 0.02) and biliary ductal dilation (p = 0.027). An H-MCNs risk predictive nomogram was constructed, which showed excellent discrimination (areas under the receiver operating characteristic curve were 0.940) and consistent calibration between the predicted probability and actual probability.
CONCLUSION: Among patients with H-MCNs, the location of the tumour, enhancement in CT scan, and biliary duct dilation are significantly independent risk factors. The appropriate treatment of H-MCNs is radical resection. Using our Nomogram could facilitate screening and identification of patients with liver cystic lesions.

Entities:  

Keywords:  Cystadenoma; Diagnosis; Liver; Surgical procedures

Mesh:

Year:  2021        PMID: 33743655      PMCID: PMC7981987          DOI: 10.1186/s12893-021-01110-9

Source DB:  PubMed          Journal:  BMC Surg        ISSN: 1471-2482            Impact factor:   2.102


  24 in total

1.  Benign tumors of the liver. VI. Multilocular cystadenomas.

Authors:  S W HENSON; H K GRAY; M B DOCKERTY
Journal:  Surg Gynecol Obstet       Date:  1957-05

2.  Intraductal papillary neoplasms and mucinous cystic neoplasms of the hepatobiliary system: demographic differences between Asian and Western populations, and comparison with pancreatic counterparts.

Authors:  Yoh Zen; Kee-Taek Jang; Soomin Ahn; Dong Hun Kim; Dong Wook Choi; Seong Ho Choi; Jin Seok Heo; Matthew M Yeh
Journal:  Histopathology       Date:  2014-04-26       Impact factor: 5.087

3.  Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor.

Authors:  Dean J Arnaoutakis; Yuhree Kim; Carlo Pulitano; Victor Zaydfudim; Malcolm H Squires; David Kooby; Ryan Groeschl; Sorin Alexandrescu; Todd W Bauer; Mark Bloomston; Kevin Soares; Hugo Marques; T Clark Gamblin; Irinel Popescu; Reid Adams; David Nagorney; Eduardo Barroso; Shishir K Maithel; Michael Crawford; Charbel Sandroussi; Wallis Marsh; Timothy M Pawlik
Journal:  Ann Surg       Date:  2015-02       Impact factor: 12.969

Review 4.  Biliary cystadenoma: a case report and review of the literature.

Authors:  R Fairchild; J Reese; H Solomon; P Garvin; R Esterl
Journal:  Mo Med       Date:  1993-10

5.  Cystadenoma and cystadenocarcinoma of the liver: a single center experience.

Authors:  David P Vogt; J Michael Henderson; Elaine Chmielewski
Journal:  J Am Coll Surg       Date:  2005-05       Impact factor: 6.113

Review 6.  Cystic neoplasms of the liver: biliary cystadenoma and cystadenocarcinoma.

Authors:  Kevin C Soares; Dean J Arnaoutakis; Ihab Kamel; Robert Anders; Reid B Adams; Todd W Bauer; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-09-14       Impact factor: 6.113

7.  Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.

Authors:  K Devaney; Z D Goodman; K G Ishak
Journal:  Am J Surg Pathol       Date:  1994-11       Impact factor: 6.394

8.  Intracystic concentrations of tumour markers for the diagnosis of cystic liver lesions.

Authors:  D Fuks; H Voitot; V Paradis; J Belghiti; V Vilgrain; O Farges
Journal:  Br J Surg       Date:  2014-01-29       Impact factor: 6.939

9.  Diagnosis and treatment of intrahepatic biliary cystadenoma: experience with 14 cases in a single center.

Authors:  Kewei Wang; Fanmin Kong; Ming Dong; Jianping Zhou; Yuji Li
Journal:  Med Oncol       Date:  2014-10-07       Impact factor: 3.064

10.  Laparoscopic Anatomical Left Hepatectomy for Intrahepatic Bile Duct Papillary Mucinous Cystadenoma With Intraoperative Vascular Repair: A Case Report.

Authors:  Hongyu Li; Bing Peng
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

View more
  1 in total

1.  Mucinous cystic neoplasm of the liver: A case report.

Authors:  Tian-Yang Yu; Jing-Song Zhang; Kai Chen; Ai-Jun Yu
Journal:  World J Clin Cases       Date:  2021-12-26       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.